BioLife Solutions Inc (BLFS)

Return on total capital

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands -70,823 -106,939 -89,896 -151,179 -145,541 -114,735 -114,154 -42,146 -35,160 -22,104 -12,075 -23,900 -610 6,241 17,641 38,274 -3,193 -3,592 -12,667 -15,635
Long-term debt US$ in thousands 18,311 20,937 23,572 23,692 23,793 24,207 6,188 6,313 6,353 6,122 5,019 916 655
Total stockholders’ equity US$ in thousands 337,663 332,017 352,128 358,107 364,188 405,120 409,544 476,075 478,047 489,259 452,281 208,777 204,429 186,851 105,843 67,709 43,321 35,191 2,072 -3,740
Return on total capital -19.90% -30.30% -23.93% -39.60% -37.51% -26.72% -27.46% -8.74% -7.26% -4.46% -2.64% -11.40% -0.30% 3.34% 16.67% 56.53% -7.37% -10.21% -611.34%

December 31, 2023 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $-70,823K ÷ ($18,311K + $337,663K)
= -19.90%

BioLife Solutions Inc's return on total capital has exhibited significant volatility over the past few quarters, ranging from -611.34% in the first quarter of 2019 to a high of 56.53% in the first quarter of 2020. However, the company experienced negative returns in most quarters, with the latest data showing -19.90% as of December 31, 2023. This negative trend indicates that the company may be facing challenges in generating returns on the total capital employed in its operations. Further analysis and investigation into the factors contributing to this trend are warranted to understand the company's financial performance and sustainability in the long run.


Peer comparison

Dec 31, 2023